Follow the Tatva Chintan Pharma Chem Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Tatva Chintan Pharma Chem Limited has recorded 7 insider filings. Market capitalisation: €40bn. The latest transaction was filed on 9 February 2026 (Purchase). Among the most active insiders: Ajay Mansukhlal Patel. All data is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€13m
6 ops.
Sell Volume
10Σ signal
Buys n/a€13m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,607 of 29,064 companies
43.1
score / 100
Value
25
Quality
62
FCF yld-2.1%
Earn yld1.1%
EV/EBITDA42.6x
ROE5.5%
Gross mgn56%
Net mgn8.3%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.